Like Philadelphia’s 18th century polymath and inventor, Ben Franklin, we at Oracle Health Sciences are innovators, too, and are focused on helping the life...
Like Philadelphia’s 18th century polymath and inventor, Ben Franklin, we at Oracle Health Sciences are innovators, too, and are focused on helping the life sciences industry find smarter ways to conduct clinical trials. On April 8-10, we’re bringing that innovation in the form of optimized, cloud-based, clinical trial solutions to the City of Brotherly Love with our annual Oracle Health Sciences Connect event. Read on and register now!
Like Philadelphia’s 18th century polymath and inventor, Ben Franklin, we at Oracle Health Sciences are innovators, too, and are focused on helping the life sciences industry find smarter ways...
At Oracle Health Sciences, we eat, sleep, think, and dream about all things related to clinical development, safety, and pharmacovigilance! Our excitement is...
At Oracle Health Sciences, we eat, sleep, think, and dream about all things related to clinical development, safety, and pharmacovigilance! Our excitement is expressed in the continuous innovation that we add to our solutions to help get new patient therapies to market faster and more efficiently. Here is an update on recent and upcoming product releases.
At Oracle Health Sciences, we eat, sleep, think, and dream about all things related to clinical development, safety, and pharmacovigilance! Our excitement is expressed in the continuous innovation...
Today, there are many obstacles in planning clinical trials. Complex study requirements, global patient populations, the need for shorter timelines, limited...
Today, there are many obstacles in planning clinical trials. Complex study requirements, global patient populations, the need for shorter timelines, limited personnel, and constrained financial resources, all contribute to making study planning a prolonged and difficult exercise for life sciences sponsors. Further, outsourcing all or part of these studies to a contract research organization (CRO) can add another layer of complexity. Clinical organizations need a way to plan...
Today, there are many obstacles in planning clinical trials. Complex study requirements, global patient populations, the need for shorter timelines, limited personnel, and constrained...
Medical device studies pose several unique challenges, many of which can be managed with targeted eClinical solutions such as InForm and CTMS.
Real World Evidence (RWE) is a very hot topic today. There is an endless opportunity for it when one considers combining Artificial Intelligence (AI) techniques...
Real World Evidence (RWE) is a very hot topic today. There is an endless opportunity for it when one considers combining Artificial Intelligence (AI) techniques on top of such a valuable digital asset cache! Oracle takes a look at it from both the business and technical perspectives.
Real World Evidence (RWE) is a very hot topic today. There is an endless opportunity for it when one considers combining Artificial Intelligence (AI) techniques on top of such a valuable digital asset...
With the incredible growth in the amount of data generated by a trial, data consolidation has also become a necessity. As data continues to stream in from...
With the incredible growth in the amount of data generated by a trial, data consolidation has also become a necessity. As data continues to stream in from multiple sources, sensors, and mobile devices, the time is rapidly approaching where data sets can typically average 500 gigabytes to a terabyte in size. For biopharmaceutical companies, the question isn’t whether they need to adopt a unified data management strategy. The real question is how to engage in this transition...
With the incredible growth in the amount of data generated by a trial, data consolidation has also become a necessity. As data continues to stream in from multiple sources, sensors, and...
The Life Sciences industry is changing rapidly. But today’s core trial platform technology continues to force both trial processes and data to be siloed and...
The Life Sciences industry is changing rapidly. But today’s core trial platform technology continues to force both trial processes and data to be siloed and does not allow for the kind of rapid innovation the industry requires. To stay on pace with rapid change, innovation must be applied to our clinical trial processes so that they can offer quick ways to advance trial processes.
The Life Sciences industry is changing rapidly. But today’s core trial platform technology continues to force both trial processes and data to be siloed and does not allow for the kind of...
Before the full potential of healthcare data can be realized, the industry needs to overcome a significant roadblock: a lack of standards for how all kinds of...
Before the full potential of healthcare data can be realized, the industry needs to overcome a significant roadblock: a lack of standards for how all kinds of healthcare- related structured and unstructured data is stored and shared among different groups, including researchers, hospitals, insurance companies, and other payers. The adoption of FHIR as a global standard, providing a technology specification to exchange, integrate, share, and retrieve electronic health...
Before the full potential of healthcare data can be realized, the industry needs to overcome a significant roadblock: a lack of standards for how all kinds of healthcare- related structured...
The number one barrier to adopting mHealth/ digital into clinical trials is not whether the technology is ready, or whether there are enough sensors or...
The number one barrier to adopting mHealth/ digital into clinical trials is not whether the technology is ready, or whether there are enough sensors or validated digital endpoints (all these are important); but it is because the execution involves change, the biggest hurdle. However there is huge opportunity that can be gained from this kind of change when comparing the traditional data management world of today with the data-science-centric world of tomorrow, enabled by...
The number one barrier to adopting mHealth/ digital into clinical trials is not whether the technology is ready, or whether there are enough sensors or validated digital endpoints (all these...
